on 18 Sep 2024
Last Applicant/ Owned by
JOHNSON & JOHNSON
One Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001
US
Serial Number
2055525 filed on 02th Oct 2020
Correspondent Address
SUITE 2600, 160 ELGIN STREETOTTAWA
ONTARIO
CA
K1P1C3
LAZERTINIB LOGO (COLOUR)
Vienna Information
26 . 2 . 1
Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)
26 . 2 . 5
Joined or intersecting segments or sectors of circles or ellipsesSegments ou secteurs de cercle ou d'ellipse, accolés ou se coupant
26 . 2 . 24
Segments or sectors of circles or ellipses, semi-circles or semi-ellipses with dark surfaces or parts of surfacesSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses avec surface ou partie de la surface foncée
26 . 1 . 1
CirclesCercles
26 . 1 . 3
One circle or ellipseUn cercle ou une ellipse
26 . 1 . 24
Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée
26 . 1 . 26
Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées
29 . 1 . 3
GreenVert
29 . 1 . 4
BlueBleu
29 . 1 . 1
Red, pink, orangeRouge, rose, orangé
29 . 1 . 2
Yellow, goldJaune, or
Trademark usage description
human pharmaceuticals for the treatment of oncologic diseasesClassification Information
Class [005]
Human pharmaceuticals for the treatment of oncologic diseases
Classification kind code
11
Mark Details
Serial Number
2055525
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 42 on 18th Sep 2024 | Advertised |
| Submitted for opposition 27 on 26th Aug 2024 | Approval Notice Sent |
| Submitted for opposition 26 on 26th Aug 2024 | Approved |
| Submitted for opposition 22 on 16th Aug 2024 | Search Recorded |
| Submitted for opposition 287 on 21st Jun 2022 | Pre-Assessment Letter Sent |
| Submitted for opposition 30 on 02th Oct 2020 | Filed |
| Submitted for opposition 1 on 02th Oct 2020 | Created |
| Submitted for opposition 31 on 02th Oct 2020 | Formalized |